GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,398.00
+5.50 (0.39%)
Jul 28, 2025, 6:43 PM BST
GSK plc Market Cap
GSK plc has a market cap or net worth of 56.21 billion as of July 28, 2025. Its market cap has decreased by -7.98% in one year.
Market Cap
56.21B
Enterprise Value
69.66B
Revenue
31.53B
Ranking
n/a
PE Ratio
18.29
Stock Price
1,398.00
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 64.68B to 56.21B, a decrease of -13.09%. That is a compound annual growth rate of -0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 56.21B | 2.31% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | 66.80B | -24.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.50B |
| Haleon | 32.84B |
| Smith & Nephew | 10.27B |
| ConvaTec Group | 4.90B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.21B |
| Oxford Nanopore Technologies | 2.02B |
| Genus | 1.61B |